NASDAQ:ITMR

Itamar Medical (ITMR) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$30.87
$30.87
50-Day Range
$30.54
$30.87
52-Week Range
$16.36
$30.91
Volume
N/A
Average Volume
90,796 shs
Market Capitalization
$497.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ITMR stock logo

About Itamar Medical Stock (NASDAQ:ITMR)

Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. It develops and markets two products, namely, WatchPAT and EndoPAT. The WatchPAT diagnoses sleep apnea, which has been proven to be a substantial risk factor in cardiac disease. The EndoPAT diagnoses endothelial malfunction, which is a proven predictor of cardiovascular disease. The company was founded by Yaron Giora , Martin Gerstel, Peretz Lavie, and Daniel Gur on January 15, 1997 and is headquartered in Caesarea, Israel.

ITMR Stock News Headlines

ITMR Historical Data
Read Your Way Around the World
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Find the Best Medical Schools
Sarit Packer and Itamar Srulovich
ZOLL Announces Closing of Acquisition of Itamar Medical
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Itamar Medical ADSs Rally on Zoll Medical Deal >ITMR
Itamar Medical Earnings Miss, Revenue Beats In Q2
See More Headlines
Receive ITMR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Itamar Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/18/2021
Today
4/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:ITMR
Fax
N/A
Employees
257
Year Founded
1997

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$41.03 million

Miscellaneous

Free Float
N/A
Market Cap
$497.25 million
Optionable
Not Optionable
Beta
0.73

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Gilad Glick
    President, CEO & VP-Sales & Marketing
  • Shy Basson
    Chief Financial Officer
  • Efrat Litman
    Vice President-Advanced Research & Development
  • Jennifer Cook
    Global Medical Director
  • Eilon Livne
    VP-Sales & Channels Development

ITMR Stock Analysis - Frequently Asked Questions

How were Itamar Medical's earnings last quarter?

Itamar Medical Ltd. (NASDAQ:ITMR) posted its earnings results on Thursday, November, 18th. The company reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by $0.32. The business earned $13.57 million during the quarter, compared to the consensus estimate of $13.70 million.

What other stocks do shareholders of Itamar Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Itamar Medical investors own include Gilead Sciences (GILD), AbbVie (ABBV), Carnival Co. & (CCL), Energy Transfer (ET), KeyCorp (KEY), Occidental Petroleum (OXY), Pfizer (PFE), Wells Fargo & Company (WFC) and Abbott Laboratories (ABT).

Does Itamar Medical have any subsidiaries?
The following companies are subsidiares of Itamar Medical: I.M.E. 2016 B.V., Itamar Medical Inc., and Itamar Medical Japan Co. Ltd..
Read More
This page (NASDAQ:ITMR) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners